Gritstone Bio
Gritstone Bio is a biotech company focused on developing next-generation vaccines for cancer and infectious diseases, supported by distinguished scientific foun
Company facts
- Founded
- 2015
- Employees
- 500
- Headquarters
- United States
- Type
- Enterprise
About
Gritstone Bio is a biotech company focused on developing next-generation vaccines for cancer and infectious diseases, supported by distinguished scientific founders, a diverse leadership team, and an experienced board. Leveraging a unique immuno-oncology platform, it targets tumor-specific neoantigens and viral antigens to harness the immune system’s ability to recognize and eliminate diseased cells. By integrating artificial intelligence, machine learning, and deep learning for epitope discovery, Gritstone delivers both personalized and off-the-shelf cancer vaccines, including solutions for colorectal cancer and MSS-CRC. The firm’s cross-cutting expertise in oncology, infectious disease, translational medicine, and drug development positions it as a leader in innovative, patient-centric immunotherapies.